Selected year-end account balances from the adjusted trial balance as of December 31, 2022, for Novak Corp, is provided below. incomesimmary (To close revenue account) Dec. 31 incorne Summary 133340 Depreciation Exponse Sularies and Wages Expense Rent Expense Sioplies Epense (To dose expense accounts) Dec. 31 income Summary Retained Exenine: (To dose net incame to retained earnings) Dec, 31 Retained Earminis 32090 Dividends Determine the post-closing balance in Retained Earnings. (Post entries in the order of journal entries presented in the previous part.)